Nanomedicine News RSS Feed - Nanomedicine

European Nanomedicine Characterization Laboratory Holds Promise for Overcoming Cancer and Other Key Diseases

European Nanomedicine Characterization Laboratory Holds Promise for Overcoming Cancer and Other Key Diseases

The ?uropean Nanomedicine Characterization Laboratory?(EU-NCL), which was launched on 1 June 2015, has a clear-cut goal: to help bring more nanomedicine candidates into the clinic and on the market, for the benefit of patients and the European pharmaceutical industry. To achieve this, EU-NCL is partnered with the sole international reference facility, the ?anotechnology Characterization Laboratory?(US-NCL) of the US-National Cancer Institute, to get faster international harmonization of analytical protocols. [More]
Electron Cryo-Microscopy Offers Extraordinary Details of Proteasome Complex

Electron Cryo-Microscopy Offers Extraordinary Details of Proteasome Complex

Scientists have pioneered the use of a high-powered imaging technique to picture in exquisite detail one of the central proteins of life - a cellular recycling unit with a role in many diseases. [More]
Implantable Microfluid System Can Efficiently, Durably Stabilize Intraocular Pressure

Implantable Microfluid System Can Efficiently, Durably Stabilize Intraocular Pressure

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. [More]
Magnetic, Nanoscale Robotic Beads Target Blocked Arteries

Magnetic, Nanoscale Robotic Beads Target Blocked Arteries

Swarms of microscopic, magnetic, robotic beads could be scrubbing in next to the world's top vascular surgeons--all taking aim at blocked arteries. [More]
NIH Awards NDSU Researcher $1.35 Million Grant to Develop Targeted Colorectal Cancer Treatment

NIH Awards NDSU Researcher $1.35 Million Grant to Develop Targeted Colorectal Cancer Treatment

A researcher at North Dakota State University, Fargo, is receiving a four-year $1.35 million research project grant from the National Cancer Institute of the National Institutes of Health to develop a targeted treatment for colorectal cancer. [More]
NANOBIOTIX Authorized to Commence NBTXR3 Clinical Trial in Liver Cancers

NANOBIOTIX Authorized to Commence NBTXR3 Clinical Trial in Liver Cancers

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has been authorized to begin a new clinical trial in liver cancers for its lead NanoXray product, NBTXR3. [More]
CEA-Leti Launches European Nano-Characterisation Laboratory Funded by the Horizon 2020 Programme

CEA-Leti Launches European Nano-Characterisation Laboratory Funded by the Horizon 2020 Programme

CEA-Leti today announced the launch of the European Nano-Characterisation Laboratory (EU-NCL) funded by the European Union? Horizon 2020 research and innovation programme. [More]
Tiny Gel Particles Attached with Nanobodies Perform the Functions of Platelets

Tiny Gel Particles Attached with Nanobodies Perform the Functions of Platelets

NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy. [More]
High-Speed AFM Helps Image Physical Properties of Live Breast Cancer Cells

High-Speed AFM Helps Image Physical Properties of Live Breast Cancer Cells

Researchers who developed a high-speed form of atomic force microscopy have shown how to image the physical properties of live breast cancer cells, for the first time revealing details about how deactivation of a key protein may lead to metastasis. [More]
Nanoparticles Packed with Chemotherapy and Coated with Chitosan Could Effectively Kill Cancer Stem-Like Cells

Nanoparticles Packed with Chemotherapy and Coated with Chitosan Could Effectively Kill Cancer Stem-Like Cells

Nanoparticles packed with a clinically used chemotherapy drug and coated with an oligosaccharide derived from the carapace of crustaceans might effectively target and kill cancer stem-like cells, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). Cancer stem-like cells have characteristics of stem cells and are present in very low numbers in tumors. [More]